METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS

(19)

(11)

EP 2 331 072 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	26.08.2020 Bulletin 2020/35

(45)	Mention of the grant of the patent:
	22.07.2020 Bulletin 2020/30

(21)	Application number: 09807991.6

(22)	Date of filing: 11.08.2009

(51)

International Patent Classification (IPC):

A61K 9/14^(2006.01)
A61K 38/57^(2006.01)
A61K 9/20^(2006.01)

A61K 38/56^(2006.01)
A61K 38/29^(2006.01)

(86)	International application number:
	PCT/IL2009/000786

(87)	International publication number:
	WO 2010/020978 (25.02.2010 Gazette 2010/08)

(54)	METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ORALEN VERABREICHUNG VON PROTEINEN MÉTHODES ET COMPOSITIONS POUR L ADMINISTRATION DE PROTÉINES PAR VOIE ORALE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)

Priority:

18.08.2008 US 89812 P

(43)	Date of publication of application:
	15.06.2011 Bulletin 2011/24

(60)	Divisional application:
	20186801.5

(73)	Proprietor: Entera Bio Ltd.
	9112002 Jerusalem (IL)

(72)	Inventors:
	KIDRON, Miriam 93706 Jerusalem (IL) ARBIT, Ehud Englewood, New Jersey 07631 (US)

(74)	Representative: Mewburn Ellis LLP
	Aurora Building Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB)

(56)

References cited: :

EP-B1- 0 817 643
WO-A2-2007/121471
US-A1- 2007 087 957

WO-A1-2005/002549
US-A1- 2006 234 913
US-A1- 2007 087 957

QI R ET AL: "Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS, BASINGSTOKE, GB, vol. 21, no. 1, 1 February 2004 (2004-02-01), pages 37-45, XP009128869, ISSN: 0265-2048, DOI: 10.1080/02652040410001653786


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).